Manning & Napier Group Portfolio holdings
Top Buys
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$115M |
| 2 |
Meta Platforms (Facebook)
META
|
+$86.1M |
| 3 |
Micron Technology
MU
|
+$68M |
| 4 |
ServiceNow
NOW
|
+$41.5M |
| 5 |
Core Laboratories
CLB
|
+$40.3M |
Top Sells
| 1 |
Ball Corp
BALL
|
+$190M |
| 2 |
Novartis
NVS
|
+$96.7M |
| 3 |
FedEx
FDX
|
+$71.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$63.5M |
| 5 |
Booking.com
BKNG
|
+$62.4M |
Sector Composition
| 1 | Healthcare | 17.86% |
| 2 | Financials | 17.52% |
| 3 | Consumer Staples | 13.57% |
| 4 | Technology | 11.26% |
| 5 | Consumer Discretionary | 9.58% |
Similar funds
Manning & Napier Group's Q2 2019 Portfolio in Review
As of Q2 2019, Manning & Napier Group held 372 positions worth $9.2B, up 0.74% from $9.14B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Manning & Napier Group withdrew a net $297M in Q2 2019, closing 49 positions and reducing 71 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $63.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Manning & Napier Group opened a new position in Activision Blizzard worth $118M.
- Manning & Napier Group's largest Q2 2019 buy was Activision Blizzard: 2,509,296 shares worth $118M.
- Manning & Napier Group added most to ServiceNow in Q2 2019, an estimated $41.5M increase.
- Manning & Napier Group's biggest Q2 2019 reduction was Ball Corp, cutting an estimated $190M.
- Manning & Napier Group fully exited Regeneron Pharmaceuticals in Q2 2019, selling an estimated $63.5M.
- Manning & Napier Group's ten largest holdings make up 27% of its $9.2B portfolio in Q2 2019.
- Manning & Napier Group opened 42 new positions and closed 49 in Q2 2019.
- Manning & Napier Group's portfolio value rose 0.74% quarter-over-quarter to $9.2B.
Based on Manning & Napier Group's 13F filing for Q2 2019, filed 24 Jul 2019.